SCHEMBL31000949

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C

nearest known ligand 0.75

Predicted protein targets (top 4)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	20/20	0.75

▸	ECE1	P42892	1/20	0.66

▸	MUS81	Q96NY9	1/20	0.66

▸	CCKBR	P32239	1/20	0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906511	0.98	GLP1R (0.71)	GLP1RECE1MUS81CCKBR
SCHEMBL30906532	0.98	GLP1R (0.71)	GLP1RECE1MUS81CCKBR
SCHEMBL30906503	0.95	GLP1R (0.72)	GLP1RECE1MUS81CCKBR
SCHEMBL30906493	0.95	GLP1R (0.70)	GLP1RECE1MUS81CCKBR
SCHEMBL30906555	0.95	GLP1R (0.68)	GLP1RECE1MUS81CCKBR
SCHEMBL30906486	0.95	GLP1R (0.70)	GLP1RECE1MUS81CCKBR
SCHEMBL30906510	0.95	GLP1R (0.67)	GLP1RECE1MUS81CCKBR
SCHEMBL30906411	0.94	GLP1R (0.72)	GLP1RECE1MUS81CCKBR
SCHEMBL30906465	0.94	GLP1R (0.72)	GLP1RECE1MUS81
SCHEMBL30906516	0.94	GLP1R (0.72)	GLP1RECE1MUS81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4630447-A2	ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF	Abwiz Bio, Inc. (US)	2025-10-15	—	—	EP	disclosed
WO-2024124241-A2	ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF	ABWIZ BIO, INC. (US)	2024-06-13	—	—	WO	disclosed